Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Platelet function inhibitors

Citations 171-180 of 251 total displayed.

Past content (since Oct 2000):

Correspondence
Platelet Glycoprotein IIb/IIIa Inhibitors
H. Richard Hellstrom
Circulation 2003;107:e39, doi:10.1161/01.CIR.0000053955.01455.5A [Full text]  

Clinical Investigations and Reports
Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease
Rémy Chenevard, David Hürlimann, Markus Béchir, Frank Enseleit, Lukas Spieker, Matthias Hermann, Walter Riesen, Steffen Gay, Renate E. Gay, Michel Neidhart, Beat Michel, Thomas F. Lüscher, Georg Noll, and Frank Ruschitzka
Circulation 2003;107:405-409; published online before print as doi:10.1161/01.CIR.0000051361.69808.3A [Abstract] [Full text]  

Clinical Investigations and Reports
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV—Acute Coronary Syndrome) Trial
J.P. Ottervanger, P. Armstrong, E.S. Barnathan, E. Boersma, J.S. Cooper, E.M. Ohman, S. James, E. Topol, L. Wallentin, M.L. Simoons for the GUSTO IV-ACS Investigators
Circulation 2003;107:437-442; published online before print as doi:10.1161/01.CIR.0000046487.06811.5E [Abstract] [Full text]  

Clinical Investigations and Reports
Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide
Shaun G. Goodman, David Fitchett, Paul W. Armstrong, Mary Tan, Anatoly Langer for the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial Investigators
Circulation 2003;107:238-244; published online before print as doi:10.1161/01.CIR.0000050144.67910.13 [Abstract] [Full text]  

Brief Rapid Communications
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
Anetta Undas, Wojciech J. Sydor, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation 2003;107:17-20; published online before print as doi:10.1161/01.CIR.0000047062.03282.A3 [Abstract] [Full text]  

Clinical Investigations and Reports
Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation: A New Drug–Drug Interaction
Wei C. Lau, Lucy A. Waskell, Paul B. Watkins, Charlene J. Neer, Kevin Horowitz, Amy S. Hopp, Alan R. Tait, David G.M. Carville, Kirk E. Guyer, and Eric R. Bates
Circulation 2003;107:32-37; published online before print as doi:10.1161/01.CIR.0000047060.60595.CC [Abstract] [Full text]  

Articles
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina. One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV—Acute Coronary Syndrome) Trial
J. P. Ottervanger, P. Armstrong, E. S. Barnathan, E. Boersma, J. S. Cooper, E. M. Ohman, S. James, E. Topol, L. Wallentin, M. L. Simoons for the GUSTO IV-ACS Investigators
Circulation published January 6, 2003, doi:10.1161/01.CIR.0000046487.06811.5E [Abstract]  

Correspondence
Aspirin Resistance Aspirin Resistance Response
Jorge Rouvier, Alejandra Scazziota, Raúl Altman, Jonathan D. Smout, Gerard Stansby, John W. Eikelboom, Jack Hirsh, Jeffrey I. Weitz, Marilyn Johnston, Qilong Yi, and Salim Yusuf
Circulation 2002;106:e200-201e, doi:10.1161/01.CIR.0000041810.21243.DB [Full text]  

Editorials
Platelet Glycoprotein IIb/IIIa Inhibition and Atheroembolism During Bypass Graft Angioplasty: A Cup Half Full
Dean J. Kereiakes
Circulation 2002;106:2994-2996, doi:10.1161/01.CIR.0000041222.31560.65 [Full text]  

Clinical Investigations and Reports
Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials
Marco Roffi, Debabrata Mukherjee, Derek P. Chew, Deepak L. Bhatt, Leslie Cho, Mark A. Robbins, Khaled M. Ziada, Danielle M. Brennan, Stephen G. Ellis, and Eric J. Topol
Circulation 2002;106:3063-3067; published online before print as doi:10.1161/01.CIR.0000041250.89627.A9 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

* Subspecialty Collections Home

* Show  Platelet function inhibitors
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors